Leal Therapeutics announces USD30m Series A extension and initiates Phase 1b/2a clinical trial of LTX-001 in schizophrenia

Can-Fite reports preclinical data supporting Phase IIb pancreatic cancer study

Acurx receives FDA conditional acceptance for ibezapolstat brand name

AstraZeneca reports positive Phase III results for Tagrisso and Orpathys

OmniAb signs global ion channel collaboration with Eli Lilly

HUTCHMED reports positive Phase III results for ORPATHYS and TAGRISSO combination

Phanes Therapeutics' Spevatamig receives US FDA Fast Track designation in advanced and metastatic biliary tract carcinoma

ArkBio's Ziresovir gains US FDA Phase II clinical trial approval

Elephas Biosciences partners Neuberg Diagnostics

Pilot Project between BioCytics and LIDE Biotech

Pharming launches Joenja in Japan for APDS patients aged four and above

PTC to acquire BLA-stage ST-920 Fabry disease programme

ArkBio's IND application for AFC candidate AK0406 approved in China for influenza prophylaxis

Definium Therapeutics reports positive Phase 3 results for DT120 in generalised anxiety disorder

Astorg completes acquisition of Thermo Fisher Scientific's microbiology business